{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:11:11Z","timestamp":1790687471444,"version":"4.1.0"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,4,12]]},"DOI":"10.18632\/oncotarget.7319","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T09:36:15Z","timestamp":1455183375000},"page":"19589-19600","source":"Crossref","is-referenced-by-count":50,"title":["Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis"],"prefix":"10.18632","volume":"7","author":[{"given":"Mu","family":"Hao","sequence":"first","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"},{"name":"Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Zang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Molecular Physiology and Biophysics, Holden Comprehensive Cancer Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Deng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Qi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"An","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Sui","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjun","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Yi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Zou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghuang","family":"Zhan","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,11]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Rajkumar","year":"2008","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1200\/JCO.2012.47.7901","article-title":"International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease","volume":"31","author":"Merlini","year":"2013","journal-title":"Journal of clinical oncology"},{"key":"3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature07242","article-title":"The impact of microRNAs on protein output","volume":"455","author":"Bartel","year":"2008","journal-title":"Nature"},{"key":"4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3109\/10428194.2011.576791","article-title":"Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression","volume":"52","author":"Qiu","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1756-8722-4-37","article-title":"Suppressing miRNA-15a\/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells","volume":"4","author":"Qiu","year":"2011","journal-title":"J Hematol Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature13375","article-title":"miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2","volume":"512","author":"Wan","year":"2014","journal-title":"Nature"},{"key":"7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm.3026","article-title":"miR-214 targets ATF4 to inhibit bone formation","volume":"19","author":"Song","year":"2013","journal-title":"Nat Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.2900060102","article-title":"The prognostic significance of X-ray changes at presentation and reassessment in patients with multiple myeloma","volume":"6","author":"Eddleston","year":"1988","journal-title":"Hematological oncology"},{"key":"9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12288-010-0033-3","article-title":"Clinical Features of Bone Complications and Prognostic Value of Bone Lesions Detected by X-ray Skeletal Survey in Previously Untreated Patients with Multiple Myeloma","volume":"26","author":"Qiu","year":"2010","journal-title":"Indian journal of hematology & blood transfusion"},{"key":"10","first-page":"228","article-title":"[The Clinical features of myeloma bone disease.]: [Article in Chinese]","volume":"31","author":"Qiu","year":"2010","journal-title":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi"},{"key":"11","doi-asserted-by":"crossref","first-page":"20794","DOI":"10.1073\/pnas.0909311106","article-title":"A microRNA regulatory mechanism of osteoblast differentiation","volume":"106","author":"Siomi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00223-015-0036-z","article-title":"Serum Circulating MicroRNAs as Biomarkers of Osteoporotic Fracture","volume":"97","author":"Garcia-Perez","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/scd.2009.0112","article-title":"MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells","volume":"19","author":"Jansen","year":"2010","journal-title":"Stem Cells Dev"},{"key":"14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2008.08.036","article-title":"The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform","volume":"112","author":"Cohn","year":"2009","journal-title":"Gynecologic oncology"},{"key":"15","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.29199","article-title":"Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma","volume":"136","author":"Qiu","year":"2015","journal-title":"Int J Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.crad.2015.02.013","article-title":"Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden","volume":"70","author":"Messiou","year":"2015","journal-title":"Clinical radiology"},{"key":"17","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Drescher","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/leu.2014.155","article-title":"Circulating miRNA markers show promise as new prognosticators for multiple myeloma","volume":"28","author":"Omede","year":"2014","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.2013.093500","article-title":"Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"99","author":"Sevcikova","year":"2014","journal-title":"Haematologica"},{"key":"20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2015.05.027","article-title":"Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation","volume":"79","author":"Hackl","year":"2015","journal-title":"Bone"},{"key":"21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bone.2015.07.006","article-title":"MicroRNA-183 increases osteoclastogenesis by repressing heme oxygenase-1","volume":"81","author":"Choi","year":"2015","journal-title":"Bone"},{"key":"22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2015.06.022","article-title":"MicroRNA-29a mitigates glucocorticoid induction of bone loss and fatty marrow by rescuing Runx2 acetylation","volume":"81","author":"Wang","year":"2015","journal-title":"Bone"},{"key":"23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ydbio.2007.08.032","article-title":"Essential role for Dicer during skeletal muscle development","volume":"311","author":"Harfe","year":"2007","journal-title":"Developmental biology"},{"key":"24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/15476286.2015.1017205","article-title":"miR-214 promotes osteoclastogenesis by targeting Pten\/PI3k\/Akt pathway","volume":"12","author":"Xu","year":"2015","journal-title":"RNA Biol"},{"key":"25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bone.2013.04.002","article-title":"MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting Osterix","volume":"55","author":"Ma","year":"2013","journal-title":"Bone"},{"key":"26","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1158\/0008-5472.CAN-14-1026","article-title":"Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease","volume":"75","author":"Lian","year":"2015","journal-title":"Cancer research"},{"key":"27","doi-asserted-by":"crossref","first-page":"e79752","DOI":"10.1371\/journal.pone.0079752","article-title":"Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients","volume":"8","author":"Van Riet","year":"2013","journal-title":"PloS one"},{"key":"28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jcb.25266","article-title":"Risks, Benefits of Bisphosphonate Therapies","volume":"117","author":"Abrahamsen","year":"2016","journal-title":"J Cell Biochem"},{"key":"29","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1158\/1078-0432.CCR-14-0434","article-title":"Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy","volume":"20","author":"Raje","year":"2014","journal-title":"Clin Cancer Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/jid.2014.479","article-title":"miR-214 as a key hub that controls cancer networks: small player, multiple functions","volume":"135","author":"Taverna","year":"2015","journal-title":"J Invest Dermatol"},{"key":"31","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3324\/haematol.2012.070011","article-title":"Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication","volume":"98","author":"Gutierrez","year":"2013","journal-title":"Haematologica"},{"key":"32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/leu.2012.282","article-title":"Combining fluorescenthybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project","volume":"27","author":"Fonseca","year":"2013","journal-title":"Leukemia"},{"key":"33","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1038\/bcj.2011.51","article-title":"Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders","volume":"2","author":"Ohyashiki","year":"2012","journal-title":"Blood Cancer J"},{"key":"34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.leukres.2015.04.010","article-title":"Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma","volume":"39","author":"Zhan","year":"2015","journal-title":"Leuk Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Davies","year":"2012","journal-title":"Nature reviews Cancer"},{"key":"36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2013.088211","article-title":"Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value","volume":"99","author":"Qiu","year":"2014","journal-title":"Haematologica"},{"key":"37","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4049\/jimmunol.1000793","article-title":"Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten","volume":"185","author":"Iacomini","year":"2010","journal-title":"J Immunol"},{"key":"38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN","volume":"68","author":"Cheng","year":"2008","journal-title":"Cancer Res"},{"key":"39","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1038\/onc.2010.111","article-title":"TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2\/214","volume":"29","author":"Mor","year":"2010","journal-title":"Oncogene"},{"key":"40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working G","year":"2003","journal-title":"British journal of haematology"},{"key":"41","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1182\/blood-2010-10-299487","article-title":"Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1","volume":"117","author":"Avet-Loiseau","year":"2011","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:30:17Z","timestamp":1589221817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,11]]},"references-count":41,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016,4,12]]}},"alternative-id":["7319","26995755"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7319","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,11]]}}}